Edition:
India

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

10.72USD
22 Jun 2018
Change (% chg)

$0.24 (+2.29%)
Prev Close
$10.48
Open
$10.63
Day's High
$10.81
Day's Low
$10.05
Volume
1,475,073
Avg. Vol
63,203
52-wk High
$12.00
52-wk Low
$2.81

Chart for

About

Aeglea BioTherapeutics, Inc. is a biotechnology company, which is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism (IEM) and cancer. The Company's product pipeline includes AEB1102, AEB3103, AEB2109 and AEB4104. Its lead product candidate, AEB1102,... (more)

Overall

Beta: --
Market Cap(Mil.): $87.77
Shares Outstanding(Mil.): 16.45
Dividend: --
Yield (%): --

Financials

BRIEF-Aeglea Biotherapeutics Announces Proposed Public Offering

* AEGLEA BIOTHERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

18 Apr 2018

Earnings vs. Estimates